Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Tumour genomics in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib in the phase II ELIOS study | ANNALS OF ONCOLOGY |